{"transactions":[{"id":1561939,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2024-03-25T19:00:59.000Z","date":"2024-03-25","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4,"value":20000.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":341702,"source":{"system":"sec-edgar","filing":"0001654954-24-003606","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495424003606/section16.xml","form_type":"4"}},{"id":2124515,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T15:27:05.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":114131,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."}],"balance_after":114131,"derivative":{"exercise_price":1,"underlying":"Common Share","underlying_shares":114131},"source":{"system":"sec-edgar","filing":"0001654954-22-014745","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422014745/section16.xml","form_type":"4"}},{"id":2124514,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T15:27:05.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":114131,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares.The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":114131,"derivative":{"exercise_price":1,"underlying":"Common Shares","underlying_shares":114131},"source":{"system":"sec-edgar","filing":"0001654954-22-014745","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422014745/section16.xml","form_type":"4"}},{"id":2124513,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T15:27:05.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":114131,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."}],"balance_after":114131,"derivative":{"exercise_price":1.5,"underlying":"Common Share","underlying_shares":114131},"source":{"system":"sec-edgar","filing":"0001654954-22-014745","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422014745/section16.xml","form_type":"4"}},{"id":2124512,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2022-11-04T15:27:05.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":114131,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares.The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the \"Initial Exercise Date\") and will expire three years after the Initial Exercise Date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":114131,"derivative":{"exercise_price":1.5,"underlying":"Common Shares","underlying_shares":114131},"source":{"system":"sec-edgar","filing":"0001654954-22-014745","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422014745/section16.xml","form_type":"4"}},{"id":2124511,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-11-04T15:27:05.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":228262,"price":1.125,"value":256794.75,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."}],"balance_after":228262,"source":{"system":"sec-edgar","filing":"0001654954-22-014745","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422014745/section16.xml","form_type":"4"}},{"id":2124510,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-11-04T15:27:05.000Z","date":"2022-11-02","kind":"grant","acquired":true,"shares":228262,"price":1.125,"value":256794.75,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 228,262 Common Shares purchased by the reporting person for $1.1250 per Common Share.  Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2356914,"source":{"system":"sec-edgar","filing":"0001654954-22-014745","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422014745/section16.xml","form_type":"4"}},{"id":2214865,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-07-05T13:38:11.000Z","date":"2022-06-30","kind":"purchase","acquired":true,"shares":20000,"price":1.6039,"value":32078.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.52 to $1.6622. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":594812,"source":{"system":"sec-edgar","filing":"0001654954-22-009259","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422009259/section16.xml","form_type":"4"}},{"id":2251523,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-05-31T09:00:28.000Z","date":"2022-05-27","kind":"purchase","acquired":true,"shares":5000,"price":1.9198,"value":9599.0,"ownership":{"direct":true},"balance_after":574812,"source":{"system":"sec-edgar","filing":"0001654954-22-007684","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422007684/section16.xml","form_type":"4"}},{"id":2256860,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-05-25T12:13:13.000Z","date":"2022-05-24","kind":"purchase","acquired":true,"shares":2000,"price":1.7998,"value":3599.6,"ownership":{"direct":true},"balance_after":569812,"source":{"system":"sec-edgar","filing":"0001654954-22-007509","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422007509/section16.xml","form_type":"4"}},{"id":2311350,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-04-01T10:56:52.000Z","date":"2022-03-31","kind":"purchase","acquired":true,"shares":2000,"price":2.9858,"value":5971.6,"ownership":{"direct":true},"balance_after":567812,"source":{"system":"sec-edgar","filing":"0001654954-22-004413","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422004413/section16.xml","form_type":"4"}},{"id":2313010,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-31T10:52:48.000Z","date":"2022-03-30","kind":"purchase","acquired":true,"shares":2000,"price":3.0491,"value":6098.2,"ownership":{"direct":true},"balance_after":565812,"source":{"system":"sec-edgar","filing":"0001654954-22-004245","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422004245/section16.xml","form_type":"4"}},{"id":2314266,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-30T12:47:38.000Z","date":"2022-03-29","kind":"purchase","acquired":true,"shares":2000,"price":3.0168,"value":6033.6,"ownership":{"direct":true},"balance_after":563812,"source":{"system":"sec-edgar","filing":"0001654954-22-004118","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422004118/section16.xml","form_type":"4"}},{"id":2323201,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-21T10:27:12.000Z","date":"2022-03-18","kind":"purchase","acquired":true,"shares":2000,"price":3.8496,"value":7699.2,"ownership":{"direct":true},"balance_after":561812,"source":{"system":"sec-edgar","filing":"0001654954-22-003483","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422003483/section16.xml","form_type":"4"}},{"id":2324805,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-18T11:26:06.000Z","date":"2022-03-17","kind":"purchase","acquired":true,"shares":1603,"price":3.264,"value":5232.192,"ownership":{"direct":true},"balance_after":559812,"source":{"system":"sec-edgar","filing":"0001654954-22-003409","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422003409/section16.xml","form_type":"4"}},{"id":2324804,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-18T11:26:06.000Z","date":"2022-03-17","kind":"purchase","acquired":true,"shares":397,"price":3.2498,"value":1290.1706,"ownership":{"direct":true},"balance_after":558209,"source":{"system":"sec-edgar","filing":"0001654954-22-003409","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422003409/section16.xml","form_type":"4"}},{"id":2330870,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-16T11:17:57.000Z","date":"2022-03-15","kind":"purchase","acquired":true,"shares":2000,"price":2.799,"value":5598.0,"ownership":{"direct":true},"balance_after":557812,"source":{"system":"sec-edgar","filing":"0001654954-22-003224","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422003224/section16.xml","form_type":"4"}},{"id":2335596,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-14T13:59:18.000Z","date":"2022-03-11","kind":"purchase","acquired":true,"shares":5000,"price":3.0589,"value":15294.5,"ownership":{"direct":true},"balance_after":555812,"source":{"system":"sec-edgar","filing":"0001654954-22-003095","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422003095/section16.xml","form_type":"4"}},{"id":2335595,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-14T13:59:18.000Z","date":"2022-03-11","kind":"purchase","acquired":true,"shares":2000,"price":3.1788,"value":6357.6,"ownership":{"direct":true},"balance_after":550812,"source":{"system":"sec-edgar","filing":"0001654954-22-003095","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422003095/section16.xml","form_type":"4"}},{"id":2339954,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-03-10T11:10:53.000Z","date":"2022-03-09","kind":"purchase","acquired":true,"shares":1500,"price":3.0464,"value":4569.6,"ownership":{"direct":true},"balance_after":548812,"source":{"system":"sec-edgar","filing":"0001654954-22-002850","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495422002850/section16.xml","form_type":"4"}},{"id":2769400,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2021-03-29T13:02:54.000Z","date":"2020-03-29","kind":"purchase","acquired":true,"shares":2000,"price":5.23,"value":10460.0,"ownership":{"direct":true},"balance_after":547312,"source":{"system":"sec-edgar","filing":"0001654954-21-003384","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495421003384/section16.xml","form_type":"4"}},{"id":2770727,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2021-03-26T11:44:03.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":3000,"price":5.25,"value":15750.0,"ownership":{"direct":true},"balance_after":545312,"source":{"system":"sec-edgar","filing":"0001654954-21-003334","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495421003334/section16.xml","form_type":"4"}},{"id":2772072,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2021-03-25T14:43:47.000Z","date":"2021-03-24","kind":"purchase","acquired":true,"shares":5000,"price":5.16,"value":25800.0,"ownership":{"direct":true},"balance_after":542312,"source":{"system":"sec-edgar","filing":"0001654954-21-003274","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495421003274/section16.xml","form_type":"4"}},{"id":2989875,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common share warrants (Right to buy)","published_at":"2020-11-06T10:00:13.000Z","date":"2020-11-05","kind":"other","acquired":false,"shares":4628,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common shares","underlying_shares":4628},"source":{"system":"sec-edgar","filing":"0001654954-20-011925","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420011925/section16.xml","form_type":"4"}},{"id":2989874,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2020-11-06T10:00:13.000Z","date":"2020-11-05","kind":"other","acquired":true,"shares":4628,"price":4,"value":18512.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2128652,"source":{"system":"sec-edgar","filing":"0001654954-20-011925","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420011925/section16.xml","form_type":"4"}},{"id":3027104,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2020-09-18T09:23:36.000Z","date":"2020-09-17","kind":"other","acquired":true,"shares":371727,"ownership":{"direct":false,"nature":"Held by 1968160 Ontario Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pardeep Nijhawan acquired 100% of the capital stock of 1968160 Ontario Inc. which holds 371,727 common shares of the issuer, pursuant to the foreign equivalent of a domestic relations order."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":371727,"source":{"system":"sec-edgar","filing":"0001654954-20-010224","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420010224/section16.xml","form_type":"4"}},{"id":3132391,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2020-05-28T12:19:56.000Z","date":"2020-05-26","kind":"purchase","acquired":true,"shares":3000,"price":2.9797,"value":8939.1,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation (1)"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2124024,"source":{"system":"sec-edgar","filing":"0001654954-20-006029","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420006029/section16.xml","form_type":"4"}},{"id":3201070,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2020-03-19T10:34:22.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":1000,"price":1.8975,"value":1897.5,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2121024,"source":{"system":"sec-edgar","filing":"0001654954-20-002851","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420002851/section16.xml","form_type":"4"}},{"id":3201069,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2020-03-19T10:34:22.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":1000,"price":1.828,"value":1828.0,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2120024,"source":{"system":"sec-edgar","filing":"0001654954-20-002851","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420002851/section16.xml","form_type":"4"}},{"id":3201068,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2020-03-19T10:34:22.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":1000,"price":1.8978,"value":1897.8,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2119024,"source":{"system":"sec-edgar","filing":"0001654954-20-002851","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420002851/section16.xml","form_type":"4"}},{"id":3201067,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2020-03-19T10:34:22.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":1000,"price":1.8599,"value":1859.9,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2118024,"source":{"system":"sec-edgar","filing":"0001654954-20-002851","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420002851/section16.xml","form_type":"4"}},{"id":3201066,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2020-03-19T10:34:22.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":1000,"price":1.8899,"value":1889.9,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each of Pardeep Nijhawan Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2117024,"source":{"system":"sec-edgar","filing":"0001654954-20-002851","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420002851/section16.xml","form_type":"4"}},{"id":3313685,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-10T21:42:35.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":4628,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":4628,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":4628},"source":{"system":"sec-edgar","filing":"0001654954-20-000314","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420000314/section16.xml","form_type":"4"}},{"id":3313684,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-10T21:42:35.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":6942,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":6942,"derivative":{"exercise_price":4.8,"exercise_date":"2020-07-08","expiration_date":"2023-07-08","underlying":"Common Shares","underlying_shares":6942},"source":{"system":"sec-edgar","filing":"0001654954-20-000314","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420000314/section16.xml","form_type":"4"}},{"id":3313683,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":17864,"kind":"person","name":"Nijhawan Pardeep","position":1,"cik":"0001777962","reported_name":"Nijhawan Pardeep","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Executive Officer"}},{"id":92709,"kind":"organization","name":"Pardeep Nijhawan Medicine Professional Corp","position":2,"cik":"0001780021","reported_name":"Pardeep Nijhawan Medicine Professional Corp","relationship":{"ten_percent_owner":true}}],"security":"Common Shares","published_at":"2020-01-10T21:42:35.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":9255,"price":4.11,"value":38038.05,"ownership":{"direct":false,"nature":"Held by Pardeep Nijhawan Medicine Professional Corporation"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 9,255 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Each of Pardeep Medicine Professional Corporation and The Digestive Health Clinic Inc. are wholly-owned by Pardeep Nijhawan."}],"balance_after":2116024,"source":{"system":"sec-edgar","filing":"0001654954-20-000314","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780021/000165495420000314/section16.xml","form_type":"4"}}]}